(Q39139179)
Statements
1 reference
The Pharmacokinetic Characteristics of Beta-Receptor Antagonists in Man-Similarities and Differences of Clinical Relevance (English)
The pharmacokinetic characteristics of beta-receptor antagonists in man--similarities and differences of clinical relevance (English)
1 August 1976
1 reference
0 references
1 reference
6
1 reference
3 Suppl
1 reference
4-13
1 reference
1 reference
1 reference
1 reference
4
365
The metabolites of oxprenolol (Trasicor?) in man (English)
Riess
1974
721
Metabolism of propranolol (Inderal), a potent specific beta-receptor blocking agent (English)
Bond
1967
11
112
Plasma propranolol levels in adults. With observations in four children (English)
Shand
1970
13
221
Metabolism of propranolol in man: Mass spectrometric identification of four new metabolites (English)
Walle
1971
13
1665
Metabolism of propranolol in rat: The fate of the N-isopropyl group (English)
Bakke
1973
14
685
Identification of the major urinary metabolite of alprenolol in man, dog and rat (English)
Bodin
1974
7
25
Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia (English)
Ohnhaus
1974
14
26
Pharmacokinetic studies of practolol, a beta-adrenergic antagonist in man (English)
Bodem
1973
16
761
Pharmacokinetics of oral propranolol in chronic renal disease (English)
Löwenthal
1974
14
693
Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man (English)
Ablad
1974
7
17
Pharmacokinetics of pindolol in man (English)
Gugler
0 references
8
3
Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man (English)
Brunner
1975
13
685
Correlation of beta-blockade with serum practolol levels after oral administration (English)
Schneck
1972
7
243
An investigation of the relationship between beta-adrenoceptor blockade and plasma practolol concentrations in man (English)
Kumana
1974
277
211
Measurement of hydrophobicity, surface activity, local anaesthesia and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine beta-adrenergic blocking agents (English)
Hellenbrecht
1973
7
159
The disposition of propranolol. T. Elimination during oral absorption in man (English)
Shand
1972
2
347
Pharmacokinetic studies on the selective beta-1-receptor antagonist metoprolol in man (English)
Regardh
1974
14
487
Disposition of propranolol: V. Drug accumulation and steady state concentrations during chronic oral administration in man (English)
Evans
1973
14
494
Disposition of propranolol: VI. Independent variation in steady state circulating drug concentrations and half-life as a result of plasma drug binding in man (English)
Evans
1973
Identifiers
1 reference
1 reference